IHM
ARNA

Iguana Healthcare Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Iguana Healthcare Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$3.95M Buy
100,000
+50,000
+100% +$1.94M 2.6% 8
2017
Q4 		$1.7M Sell
50,000
-10,000
-17% -$285K 1.11% 36
2017
Q3 		$1.53M Buy
+60,000
New +$1.38M 0.83% 44

Other funds holding ARNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Iguana Healthcare Management's ARNA Position: Q1 2018 in Review

Iguana Healthcare Management increased its Arena Pharmaceuticals Inc (ARNA) stake by 100% in Q1 2018, buying an estimated $1.94M and bringing the position to 100,000 shares worth $3.95M. The position accounts for 2.6% of the portfolio, ranked #8.

Iguana Healthcare Management first reported a position in ARNA in Q3 2017 and has held it in 3 quarters since. 170 funds tracked by Wall St. Rank hold ARNA as of Q1 2018.

  • Iguana Healthcare Management held 100,000 shares of Arena Pharmaceuticals Inc worth $3.95M as of Q1 2018.
  • Iguana Healthcare Management bought 50,000 Arena Pharmaceuticals Inc shares in Q1 2018, an estimated $1.94M.
  • Arena Pharmaceuticals Inc made up 2.6% of Iguana Healthcare Management's portfolio in Q1 2018, its #8 holding.
  • Iguana Healthcare Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and has held it in 3 quarters since.
  • 170 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.